Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052319 · ClinicalTrials.gov registry record
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
A clinical trial of Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD), sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 277
- Enrollment target
- 6
- Study locations
NCT06052319: Completed study of Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD), sponsored by Janssen Scientific Affairs.
NCT06052319 is a study of Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD) that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 277 participants, below the 1,089-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (75% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06052319, a study of Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD), has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 277 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).
Primary Outcome
Percentage of participants (of those who onboarded the C4T CAD-PAD app) who use CAD-PAD the application for at least 10 weeks during the 3-month study period will be reported. The weekly app use is defined as using at least one component of the app once a week.
Conditions Studied
Interventions
- DEVICE Care4Today® Connect CAD-PAD Mobile Application
Study Locations (6)
Florida
- HCA Florida Memorial Hospital - Jacksonville
- University of Florida Health Jacksonville - Jacksonville
Texas
- HCA Houston Healthcare Medical Center - Houston
- Rio Grande Regional Hospital - McAllen
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Kansas
- The Kansas City Heart Rhythm Institute - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2024-08-13 |
What the finished NCT06052319 record still lists
NCT06052319 is an observational study that tracks outcomes without assigning an intervention. The registered 277 participants enrollment target is mid-sized for trials with a published cap, below the 1,089-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Coronary Artery Disease (CAD) appearing as the primary indexed condition, and to 1 intervention - of which Care4Today® Connect CAD-PAD Mobile Application is the first listed.
NCT06052319 lists 6 locations in 4 states (Florida, Texas, Colorado).
Frequently Asked Questions
What is clinical trial NCT06052319 about?
NCT06052319 is a clinical study titled "A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population". The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).
What is the current status of trial NCT06052319?
This trial is currently completed. The enrollment target is 277 participants. The study started on 2023-11-29. Estimated completion is 2024-08-13.
What conditions does trial NCT06052319 study?
This clinical trial studies the following conditions: Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD).
What interventions are being tested in trial NCT06052319?
The interventions under investigation include: Care4Today® Connect CAD-PAD Mobile Application (DEVICE).
Who is sponsoring clinical trial NCT06052319?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06052319 being conducted?
This trial has 6 study locations across Colorado, Florida, Kansas, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease (CAD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
RECRUITING
-
Using CTA Measures to Define Cardiac Risk In NFL Alumni
RECRUITING
-
Beating the Blues for Your Heart
COMPLETED · Phase 2
-
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
COMPLETED
-
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05818683 · 277 participants · Phase 1
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
- NCT06789913 · 277 participants · Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI